Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) EBITDA (2017 - 2026)

Rafael Holdings' (RFL) quarterly EBITDA came in at -$6.9 million in Q2 2026, down 16.18% year-over-year from -$8.2 million in Q2 2025, and down 3.23% quarter-over-quarter from -$6.7 million in Q1 2026.

Analysis

Rafael Holdings (RFL) EBITDA (2017 - 2026) Analysis & Trends

Rafael Holdings (RFL) has reported EBITDA for 10 consecutive years, with -$6.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EBITDA fell 16.18% year-over-year to -$6.9 million in Q2 2026; TTM through Apr 2026 was -$36.4 million, a 79.98% decrease from a year earlier, with the FY2025 full-year figure at -$29.2 million, up 71.59% from the prior year.
  • EBITDA was -$6.9 million for Q2 2026 at Rafael Holdings, down from -$6.7 million in the prior quarter.
  • Over five years, EBITDA peaked at -$1.6 million in Q1 2022 and troughed at -$93.2 million in Q2 2024.
  • A 5-year average of -$10.1 million and a median of -$4.8 million in 2022 frame the typical range for EBITDA.
  • Across the five-year window, EBITDA slumped 2992.99% in 2024 and soared 93.65% in 2025, its largest moves.
  • Over 5 years, EBITDA stood at -$5.1 million in 2022, then soared by 51.93% to -$2.5 million in 2023, then tumbled by 56.2% to -$3.8 million in 2024, then slumped by 163.81% to -$10.1 million in 2025, then surged by 32.26% to -$6.9 million in 2026.
  • The last three EBITDA figures came in at -$6.9 million (Q2 2026), -$6.7 million (Q1 2026), and -$10.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 493.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -365.99 Mn
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00 -6.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -6.87 Mn
Jan 31, 2026 -6.66 Mn
Oct 31, 2025 -10.14 Mn
Jul 31, 2025 -12.76 Mn
Apr 30, 2025 -5.91 Mn
Jan 31, 2025 -6.64 Mn
Oct 31, 2024 -3.84 Mn
Jul 31, 2024 -3.85 Mn
Apr 30, 2024 -93.16 Mn
Jan 31, 2024 -3.14 Mn
Oct 31, 2023 -2.46 Mn
Jul 31, 2023 -2.59 Mn
Apr 30, 2023 -3.01 Mn
Jan 31, 2023 -4.24 Mn
Oct 31, 2022 -5.12 Mn
Jul 31, 2022 -4.89 Mn
Apr 30, 2022 -4.67 Mn
Jan 31, 2022 -1.58 Mn
Oct 31, 2021 -49.52 Mn
Jul 31, 2021 -9.93 Mn